Dr Telma Sequeira speaks to ecancer about lung microbiome in lung cancer patients.

She examines her research exploring differences in the pulmonary microbiome between patients with lung cancer and non-cancer controls in a Portuguese population.

The study found that patients with lung cancer had a distinct microbial profile, with increased prevalence of specific organisms including Sphingomonas, Malassezia, and Moraxella catarrhalis, while other bacteria were more common in controls.

These differences were observed alongside known clinical factors such as smoking status and chronic lung disease.

These findings support the growing evidence that alterations in the lung microbiome are associated with lung cancer and highlight the importance of considering geographic and population-specific patterns in future research and potential clinical applications.